Who is sponsoring NCT06239610?

NCT06239610 is sponsored by Parkview Health.

What drugs are being tested in NCT06239610?

Interventions in NCT06239610: electromagnetic placement device.

What condition does NCT06239610 study?

NCT06239610 studies Enteral Nutrition.

Is NCT06239610 still recruiting?

NCT06239610 is currently completed. Last updated 11 August 2025.

Are results published for NCT06239610?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2025-08-11 · How we verify

NCT06239610

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

DrIFT 2 Study: Displacement in Feeding Tubes

Completed NA Results posted Last updated 11 August 2025

What this trial tests

NA trial testing electromagnetic placement device in Enteral Nutrition in 119 participants. Completed in 11 August 2024.

Timeline

19 March 2024

Primary endpoint
11 August 2024

11 August 2024

Quick facts

Lead sponsor	Parkview Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	119
Start date	19 March 2024
Primary completion	11 August 2024
Estimated completion	11 August 2024
Sites	1 location across United States

Drugs / interventions tested

electromagnetic placement device

Conditions studied

Enteral Nutrition — all drugs for Enteral Nutrition →

Sponsor

Parkview Health

Who can join

18 and older, any sex, with Enteral Nutrition. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Tube Migration Primary · 5 days or until FT removed, whichever came first

Number of participants with clincially significant feeding tube retrograde migration

Group	Value	95% CI
Feeding Tube Migration	6

Effect of ETT Extubation on FT Movement Primary · 5 days or until FT removed, whichever came first

Number of participants with clincially significant retrograde migration after extubation

Group	Value	95% CI
Feeding Tube Migration	2

Sponsor's own description

The proposed study will use an electromagnetic placement device (EMPD), Cortrak\* 2 Enteral Access System (EAS™), Avanos Medical, to verify feeding tube (FT) position on a daily basis to assess for migration. The EMPD provides real-time FT placement data. A sensor located on the distal end of the FT guidewire communicates with a receiver unit which sits on the patient's abdomen. Three visual insertion tracings with varying views (anterior, lateral, and depth/cross-section) can be saved and printed for comparison.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Enteral Nutrition

Currently open trials in the same condition.

NCT07307027 — Stepwise Enteral Nutritional Algorithm and Patient Outcomes in Pediatric Intensive Care Units · NA · recruiting

Other Parkview Health trials

Trials by the same sponsor.

NCT04558034 — The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer · NA · terminated
NCT03245580 — Benign Liver Optimal Core Study (Tissue Acquisition Comparison in Benign Liver Disease) · NA · completed
NCT02376543 — Comparison Study in Pancreatic Fiducial Placement · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06239610 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Parkview Health
Last refreshed: 11 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06239610.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing